文献速递糖尿病

2型糖尿病、神经病变与微血管功能障碍之间的关系:来自隐源性轴索型多神经病患者的证据

Relationships Between Type 2 Diabetes, Neuropathy, and Microvascular Dysfunction: Evidence From Patients With Cryptogenic Axonal Polyneuropathy.
PubMed 文献 · Diabetes Care · 2017-02-15

横断面研究比较16名健康对照、16例隐源性轴索型多神经病(CAP)、15例伴多神经病的2型糖尿病(DPN)及11例不伴多神经病的2型糖尿病患者,发现糖尿病患者的乙酰胆碱所致内皮依赖性血管舒张反应低于健康对照,而CAP患者正常;SNP所致血管舒张各组无显著差异。作者认为2型糖尿病中神经病变与微血管内皮依赖性血管舒张受损互不因果,且微血管血管舒张受损不参与CAP。

要点

  • 伴或不伴多神经病的2型糖尿病患者乙酰胆碱所致血管舒张反应均低于健康对照。
  • CAP患者乙酰胆碱所致血管舒张反应与健康对照相似。
  • SNP所致血管舒张反应在各组间无显著差异。

核心结论

  • 2型糖尿病患者无论是否伴多神经病,内皮依赖性血管舒张均降低,而CAP患者微血管血管舒张正常。
  • 数据提示2型糖尿病中神经病变不导致微血管内皮依赖性血管舒张受损,反之亦然。
  • 本研究提示微血管血管舒张受损不参与CAP。

研究设计与样本

  • 横断面研究,收集16名健康对照、16例CAP、15例伴多神经病的2型糖尿病(DPN)和11例不伴多神经病的2型糖尿病患者的信息。
  • 采用皮肤活检和神经传导检查评估轴索变性。
  • 采用激光多普勒血流仪结合乙酰胆碱(ACh)和硝普钠(SNP)离子导入测量皮肤微血管血管舒张。

主要发现

  • CAP和DPN患者与健康对照相比,表皮内神经纤维密度和腓肠感觉神经动作电位均出现相似降低。
  • ACh所致血管舒张反应:CAP患者与健康对照相似(基于对数值的相对平均差异13.3%;95%CI -35.0至97.7%;P=0.652)。
  • ACh所致血管舒张反应:伴神经病的糖尿病患者(157.5%;95%CI 42.0至366.7%;P=0.003)和不伴神经病的糖尿病患者(174.2%;95%CI 44.2至421.3%;P=0.003)均低于健康对照。
  • 两组糖尿病患者之间无显著差异(P=0.845)。
  • SNP所致血管舒张反应在各组间无显著差异(P=0.082)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study investigated whether the relationship between neuropathy and microvascular dysfunction in patients with type 2 diabetes is independent of diabetes-related factors. For this purpose, we compared skin microvascular function in patients with type 2 diabetes with that of patients with cryptogenic axonal polyneuropathy (CAP), a polyneuropathy of unknown etiology. RESEARCH DESIGN AND METHODS: Cross-sectional information was collected from 16 healthy controls (HCs), 16 patients with CAP, 15 patients with type 2 diabetes with polyneuropathy (DPN), and 11 patients with type 2 diabetes without polyneuropathy. Axonal degeneration was assessed with skin biopsy and nerve conduction studies. Microvascular skin vasodilation was measured using laser Doppler fluxmetry combined with iontophoresis of acetylcholine (ACh) and sodium nitroprusside (SNP). RESULTS: Patients with CAP and DPN demonstrated a similar decrease in intraepidermal nerve fiber density and sural sensory nerve action potential compared with HCs. The vasodilator response to ACh was similar among patients with CAP (relative mean difference based on log values 13.3%; 95% CI -35.0 to 97.7%; P = 0.652) but was lower in the patients with diabetes with neuropathy (157.5%; 42.0-366.7%; P = 0.003) and without neuropathy (174.2%; 44.2-421.3%; P = 0.003) compared with HCs. No significant differences were found between the groups of patients with diabetes (P = 0.845). The vasodilator response to SNP was not significantly different among the groups (P = 0.082). CONCLUSIONS: In this study, endothelium-dependent vasodilation was reduced in patients with type 2 diabetes regardless of the presence of polyneuropathy, whereas microvascular vasodilation was normal in patients with CAP. These data suggest that in type 2 diabetes, neuropathy does not contribute to impaired microvascular endothelium-dependent vasodilation and vice versa. In addition, this study suggests that impaired microvascular vasodilation does not contribute to CAP.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Emanuel AL, Nieuwenhoff MD, Klaassen ES, et al. Relationships Between Type 2 Diabetes, Neuropathy, and Microvascular Dysfunction: Evidence From Patients With Cryptogenic Axonal Polyneuropathy. Diabetes Care. 2017. PMID: 28202549. doi:10.2337/dc16-1690

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。